Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Learn the best actions to take with your credit card points. Make informed decisions to maximize your rewards and benefits.
25,531 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Adobe posted solid quarterly results but faces mounting downgrades as analysts question AI monetization, pricing powe...
A caller facing a $7,000 IRS bill on The Ramsey Show was urged to pay immediately to avoid steep penalties and daily-...
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...
Central Valley peach growers confront a costly and abrupt pivot after Del Monte closures. About 3,000 acres will be u...
Britain pre-positions HMS Dragon in the Middle East as part of plans for a Europe-led mission to escort ships through...
Onsemi posted weaker Q1 2026 results amid a slowing silicon carbide market and rising competition from Sony in image ...
New Rochelle's zoning reform has sparked a housing surge, signaling a blueprint for faster development and safer lend...
A new market dynamic is taking hold: memory pricing and capex discipline are steering the current semiconductor upcyc...
SolarEdge and Enphase surged as residential solar demand improved, while Canadian Solar slid, underscoring a sharp sp...
Three major brokerages are pursuing aggressive technology-driven consolidations, signaling a shift toward in-house pl...
Two years after a spouse's death, survivors face a new tax regime. This report outlines crucial 401(k) moves to reduc...